6 Priority Review Vouchers (PRVs) Issued in YTD 2024
Innovation in rare disease continues to be strong, with six Rare Pediatric Disease Priority Review Vouchers (PRVs) issued through the first four months of the year.
Bourne continues to be one of the most active Pharma Services Advisors, having closed 7 transactions with 7 different sponsors within the last 45 days with more to come! Select recent clients and counterparties include: